Literature DB >> 1549143

Amyotrophic lateral sclerosis (ALS): a phylogenetic disease of the corticomotoneuron?

A Eisen1, S Kim, B Pant.   

Abstract

It is proposed that the primary cell involved in amyotrophic lateral sclerosis (ALS) is the corticomotoneuron. The spinal motoneuron becomes affected as a result of antegrade effects. This hypothesis does not negate most of the presently popular theories regarding the pathogenesis of ALS, but directs focus to one cell type--the corticomotoneuron. It takes cognizance of the complex, monosynaptic, corticomotoneuronal-spinomotoneuronal connections that have evolved in primates, and especially in man. It might explain the lack of any natural or thus far induced animal model which closely mimics the human disease. Threshold measurements to transcotical magnetic stimulation might be used to test the hypothesis. Replication of ALS in an animal is only likely to succeed in a nonhuman primate.

Entities:  

Mesh:

Year:  1992        PMID: 1549143     DOI: 10.1002/mus.880150215

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  52 in total

1.  Advances in the application of MRI to amyotrophic lateral sclerosis.

Authors:  Martin R Turner; Michel Modo
Journal:  Expert Opin Med Diagn       Date:  2010-11

Review 2.  The epidemiology of ALS: a conspiracy of genes, environment and time.

Authors:  Ammar Al-Chalabi; Orla Hardiman
Journal:  Nat Rev Neurol       Date:  2013-10-15       Impact factor: 42.937

3.  Corpus callosum involvement is a consistent feature of amyotrophic lateral sclerosis.

Authors:  N Filippini; G Douaud; C E Mackay; S Knight; K Talbot; M R Turner
Journal:  Neurology       Date:  2010-11-02       Impact factor: 9.910

Review 4.  ALS motor phenotype heterogeneity, focality, and spread: deconstructing motor neuron degeneration.

Authors:  John M Ravits; Albert R La Spada
Journal:  Neurology       Date:  2009-09-08       Impact factor: 9.910

5.  Double cortical stimulation in amyotrophic lateral sclerosis.

Authors:  T Yokota; A Yoshino; A Inaba; Y Saito
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-12       Impact factor: 10.154

6.  Dissociated lower limb muscle involvement in amyotrophic lateral sclerosis.

Authors:  Neil G Simon; Michael Lee; Jong Seok Bae; Eneida Mioshi; Cindy S-Y Lin; Casey M Pfluger; Robert D Henderson; Steve Vucic; Michael Swash; David Burke; Matthew C Kiernan
Journal:  J Neurol       Date:  2015-04-07       Impact factor: 4.849

7.  High signal intensity on T1 weighted MRI of the anterolateral column of the spinal cord in amyotrophic lateral sclerosis.

Authors:  M Waragai; H Shinotoh; M Hayashi; T Hattori
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-01       Impact factor: 10.154

Review 8.  Presymptomatic studies in ALS: rationale, challenges, and approach.

Authors:  Michael Benatar; Joanne Wuu
Journal:  Neurology       Date:  2012-10-16       Impact factor: 9.910

Review 9.  Cortical excitability and neurology: insights into the pathophysiology.

Authors:  Radwa A B Badawy; Tobias Loetscher; Richard A L Macdonell; Amy Brodtmann
Journal:  Funct Neurol       Date:  2012 Jul-Sep

Review 10.  Clinical diagnosis and management of amyotrophic lateral sclerosis.

Authors:  Orla Hardiman; Leonard H van den Berg; Matthew C Kiernan
Journal:  Nat Rev Neurol       Date:  2011-10-11       Impact factor: 42.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.